sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Home / All latest News / Global Irritable Bowel Syndrome (IBS) Diagnostics Market

Global Irritable Bowel Syndrome (IBS) Diagnostics Market Projected to Reach USD 2.3 Billion By 2026

10-Jun-2021 | Facts and Factors

The latest report published by facts and factors titled “irritable bowel syndrome (IBS) diagnostics market” has a global perspective on the latter coupled with the market size, volume, drivers, and restraints to name a few. We estimate that the global irritable bowel syndrome (IBS) diagnostics market will hold a value of USD 2.3 Billion with a CAGR growth of 9.7% which was previously subjected at USD 1.2 Billion in the year 2020.

Irritable bowel syndrome is a medical condition that pertains to irregular bowel movement and is accompanied by extreme pain in the stomach followed by diarrhoea, cramping, and constipation among others. IBS is a fairly simple diagnosis that can be detected by a range of laboratory tests and imaging tests with a wider range of medication as treatment measures. The driving factors behind the growth of the irritable bowel syndrome (IBS) diagnostics market are a rise of prevalence of factors such as food allergies, predominant development of gastroenteritis, sporadic movements of colon, irregular composition of serotonin in the colon, and a rise in celiac diseases, among others.

Request Sample Request Customization Buy Now

Additional factors include improvement in testing methods and extensive research and developmental means for improved accuracy and less down time during testing. Moreover, the approval of linzess among regions of U.S, Europe, and Asia-Pacific is expected to propel the growth of IBS diagnostic market over the forecast period. Increased awareness among consumers and a widened spending power coupled with established healthcare facilities will further lead the market toward a positive outlook.

Top Key Market Players

The key participants in the irritable bowel syndrome (IBS) diagnostics market are Synergy Pharmaceuticals, Banusch Health, Synthetic Biologics, Inc., Ardelyx, Johnson & Johnson, and Novartis AG, among others.

Market Dynamics

The market is highly unmeasured and is often accompanied by product launches, mergers & acquisitions, and constant developmental cycles among the key players in order to stay competitive. Here are a few noted developments –

  • Commonwealth Diagnostics International (CDI), Inc. recently announced the launch of commercially based validated biomarkers for diarrhoea predominated and mixed-typed irritable bowel syndrome (IBS-D, IBS-M) for home-testing solutions.
  • Gemelli Biotech recently collaborated with Advanced Medical German Co. in order to enter a previously untapped region to distribute their proprietary blood testing kits for IBS – ibs-smart.

On the basis of type, the global irritable bowel syndrome (IBS) diagnostics market can be divided into ISB-C, ISB-D, and Mixed IBS on the bases of type. The IBS-C can be further broken down into linzess/constella, amitiza, and others and the IBS-D can be broken down into xifaxan, viberzi, and others. The IBS-C segment is expected to dominate owing to various contributing factors such as a surge of uptake of drugs such as linzess/constella & amitiza.

On the basis of product, the global irritable bowel syndrome (IBS) diagnostics market can be broken down into rifaximin, eluxadoline, Lubiprostone, linaclotide, and others. The segment pertaining to rifaximin will account for the largest marker share during the advent of the forecast owing to factors such as rise in geriatric population, increased consumer spending, reliable diagnosis, and advancements in technology.

North America Will Lead The Market Over The Forecast In Terms Of Revenue

North America is expected to recoup the largest market share during the forecast in terms of global revenue collection followed by the Europe and Asia-Pacific. The market growth in North America is primarily due to the well-established healthcare facilities, government incentives, and presence of key players in the region. Moreover, rising patient awareness and increased consumer spending power for diagnostics tests will propel the growth of the irritable bowel syndrome (IBS) diagnostics market during the forecast period.

Browse the full “Irritable Bowel Syndrome (IBS) Diagnostics Market By Type (IBS-C, IBS-D, and Mixed IBS), By Product (Rifaximin, Eluxadoline, Lubiprostone, Linaclotide, & Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies & Online Pharmacies), And By Regions – Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026” report at https://www.fnfresearch.com/irritable-bowel-syndrome-diagnostics-market

The global irritable bowel syndrome (IBS) diagnostics market can be segmented into:

Global Irritable Bowel Syndrome (IBS) Diagnostics Market: By Type Segment Analysis

  • ISB-C    
    • Linzess/Constella
    • Amitiza
    • Others
  • ISB-D
    • Xifaxan
    • Viberzi
    • Others
  • Mixed IBS

Global Irritable Bowel Syndrome (IBS) Diagnostics Market: By Product Segment Analysis

  • Rifaximin
  • Eluxadoline
  • Lubiprostone
  • Linaclotide
  • Others

Global Irritable Bowel Syndrome (IBS) Diagnostics Market: By Distribution Channel Segment Analysis

  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Pharmacies

Global Irritable Bowel Syndrome (IBS) Diagnostics Market: By Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors

A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: sales@fnfresearch.com

Latest Added Market Report

Instant Noodles Market: By Type (Chicken, Vegetables, Sea Food, & Others), By Modality (Fried & Non-Fried), By Ingredient (Oats, Rice, Wheat, & Others), By Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, Online Retail, & Others), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecasts, 2021 - 2026

We at Facts Factors have recently added the market study titled Instant Noodles Market to our pool of market studies that focus solely on an analytical approach. We estimate that the market will be valued at USD 45.67 Billion in the year 2020 and will grow to an anticipated value of USD 73.55 Billion in the year 2026 with a CAGR growth of 6%. ...

Published Date : 23-Jun-2021 | | Category : Food & Beverages | Pages : 171 | Format : Read more

ePharmacy Market: By Drug Type (Over-the-Counter Products & Prescription Medicine), By Product (Skin Care, Dental, Cold & Flu, Vitamins, Weight Loss, and Other), And By Regions - Global & Regional

The recent publication titled Global ePharmacy Market has been added to our long list of market studies that aims to capture a detailed and comprehensive outlook of the respective market. We at Facts Factors estimate that an initial value of the market will be USD 51.20 Billion in the year 2020 and is expected to grow to a final value of USD 111.10 Billion in the year 2026 with a CAGR growth of 15.10%. <img src=" ...

Published Date : 23-Jun-2021 | | Category : Healthcare | Pages : 173 | Format : Read more

Medical Device Market By Type of Device (Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging, IVD, MIS, Wound Management, Diabetes Care, Ophthalmic, Dental, Nephrology & Urology, General Surgery, & Others), By End-User (Homecare, Hospitals & Clinics, & Diagnostic Centers), And By Regions – Global & Regional Industry Perspective, Comprehensive Analysis, and Forecasts, 2021 - 2026

[205+ Pages Report] The latest market study published by Facts Factors titled Medical Device Market contains the latestabout the market in terms of an analytical approach. We estimate that the globalMedical Device Market will flourish at an astounding rate of 5% CAGR during the forecast period to grow to a value of USD 623 Billion by 2026 from an initia ...

Published Date : 21-Jun-2021 | | Category : Medical Device | Pages : 205 | Format : Read more

Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2021 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions